II
ANIP icon

Inspire Investing’s ANI Pharmaceuticals ANIP Stock Holding History

Inspire Investing’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-12,520
Closed -$866K – 804
2024
Q1 		$866K Buy
+12,520
New +$756K 0.09% 259
2023
Q4 		– Sell
-10,560
Closed -$613K – 787
2023
Q3 		$613K Buy
+10,560
New +$609K 0.08% 268

Other funds holding ANIP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.67B AUM 35.09% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Inspire Investing's ANIP Position: Q2 2024 in Review

Inspire Investing sold out of ANI Pharmaceuticals (ANIP) in Q2 2024, closing a stake of 12,520 shares — an estimated $866K sold.

Inspire Investing first reported a position in ANIP in Q3 2023 and held it in 2 quarters. The position peaked at $866K in Q1 2024. 201 funds tracked by Wall St. Rank hold ANIP as of Q2 2024.

  • Inspire Investing reported no remaining ANI Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
  • Inspire Investing sold 12,520 ANI Pharmaceuticals shares in Q2 2024, an estimated $866K.
  • Inspire Investing first reported a position in ANI Pharmaceuticals in Q3 2023 and held it in 2 quarters.
  • Inspire Investing's ANI Pharmaceuticals position peaked at $866K in Q1 2024.
  • 201 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q2 2024.

Based on Inspire Investing's 13F filing for Q2 2024, filed 12 Aug 2024.